Arpita Desai, MD
|
Title(s) | HS Clinical Instructor, Medicine |
---|
School | School of Medicine |
---|
vCard | Download vCard |
---|
|
|
Biography State University of New York at Buffalo | Residency | 2015 | Internal Medicine | University of Chicago | Fellowship | 2018 | Medical Oncology |
SUNY at Buffalo | 2014 | | Dexter S. Levy Memorial Award | SUNY at Buffalo | 2015 | | Thomas F. Frawley Research Fellowship Award | ASCO | 2018 | | Conquer Cancer Foundation of ASCO/Frances A. Shepherd, MD, Endowed Merit Award | IASLC | 2018 | | Young Investigator Award |
Overview Dr. Arpita Desai is an oncologist who specializes in the treatment of patients with genitourinary cancers, in particular kidney and prostate cancers.
Desai is interested in developing novel imaging and therapeutic strategies in renal cell cancer with the goal of improving outcomes by personalizing therapy. The scope of her most recent work has been related to incorporating functional and molecular imaging to personalize treatment in GU malignancies.
Desai completed her residency in internal medicine at the State University of New York where she also served as chief resident of internal medicine. She completed a fellowship in medical oncology at the University of Chicago. She is a member of the American Society of Clinical Oncology (ASCO) and American Association for Cancer Research (AACR).
ORNG Applications Bibliographic
-
Desai A, Small EJ. Treatment of advanced renal cell carcinoma patients with cabozantinib, an oral multityrosine kinase inhibitor of MET, AXL and VEGF receptors. Future Oncol. 2019 Jul; 15(20):2337-2348. PMID: 31184937.
|
Co-Authors People in Profiles who have published with this person. _
|